Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

Abstract

Alpha 1-antitrypsin (α1AT) deficiency disease is one of the more common hereditary disorders that affects the liver and lung. The liver disease of α1AT deficiency is generally thought to be caused by the accumulation of an abnormal α1AT protein in hepatocytes, whereas the lung disease is thought to be due to a relative lack of the normal protein in the circulation. Therefore, one possible approach to prevent and treat α1AT disease is to both inhibit the expression of the mutated α1AT gene, and to provide a means of synthesizing the normal protein. To do this, we designed specific hammerhead ribozymes that were capable of cleaving the α1AT mRNA at specific sites, and constructed a modified α1AT cDNA not susceptible to ribozyme cleavage. Ribozymes were effective in inhibiting α1AT expression in a human hepatoma cell line using a newly developed simian virus (SV40) vector system. In addition, the hepatoma cell line was stably transduced with a modified α1AT cDNA that was capable of producing wild-type α1AT protein, but was not cleaved by the ribozyme that decreased endogenous α1AT expression. These results suggest that ribozymes can be employed for the specific inhibition for an abnormal α1AT gene product, the first step in designing a gene therapy for the disease. The findings also suggest that the novel SV40-derived vector may represent a fundamental improvement in the gene therapeutic armarmentarium.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Crystal R et al. The α1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy Chest 1989 95: 196–208

    Article  CAS  Google Scholar 

  2. Long G et al. Complete sequence of the cDNA for human α1 antitrypsin and the gene for the S variant J Biochem 1984 23: 4828–4837

    Article  CAS  Google Scholar 

  3. Hubbard R, Crystal R . α1-Antitrypsin deficiency Am J Med 1988 85: 52–62

    Article  Google Scholar 

  4. Crystal RG . The α1 antitrypsin gene and its deficiency states Trends Genet 1989 5: 411–417

    Article  CAS  Google Scholar 

  5. Errickson S, Carlson S, Velez R . Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency New Engl J Med 1986 314: 736–739

    Article  Google Scholar 

  6. Sifers R et al. A frameshift mutation results in a truncated α1-antitrypsin that is retained within the rough endoplasmic reticulum J Biol Chem 1988 263: 7330–7335

    CAS  PubMed  Google Scholar 

  7. Alino S et al. In vivo delivery of human α1-antitrypsin gene to mouse hepatocytes by liposomes Biochem Biophys Res Comm 1993 192: 174–181

    Article  CAS  Google Scholar 

  8. Jaffe H et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver Nat Genet 1992 1: 372–378

    Article  CAS  Google Scholar 

  9. Kay M et al. Expression of human α1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes Proc Natl Acad Sci USA 1992 89: 372–378

    Article  Google Scholar 

  10. Feng M et al. Neoplastic reversion accomplished by high efficiency adenovirus-mediated delivery of an anti-ras ribozyme Cancer Res 1995 55: 2024–2028

    CAS  Google Scholar 

  11. Kobayashi H, Dorai T, Holland JF, Ohnuma T . Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1(PGY1) ribozyme Cancer Res 1994 54: 1271–1275

    CAS  Google Scholar 

  12. Sarvar N et al. Ribozymes as potential anti-HIV-1 therapeutic agents Science 1990 247: 1222–1225

    Article  Google Scholar 

  13. Scanlon KJ et al. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein Proc Natl Acad Sci USA 1991 88: 10591–10595

    Article  CAS  Google Scholar 

  14. Shore SK, Nabissa PM, Reddy EP . Ribozyme-mediated cleavage of the BCR-ABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity Oncogene 1993 8: 3183–3188

    CAS  PubMed  Google Scholar 

  15. Yu M et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1 Proc Natl Acad Sci USA 1993 90: 6340–6344

    Article  CAS  Google Scholar 

  16. Strayer DS . SV40 as an effective gene transfer vector in vivo J Biol Chem 1996 27: 24741–24746

    Google Scholar 

  17. Strayer DS, Milano J . SV40 mediates stable gene transfer in vivo Gene Therapy 1996 3: 581–587

    CAS  PubMed  Google Scholar 

  18. Ozaki I et al. Ribozyme-mediated specific gene replacement of the α1-antitrypsin ribozyme in a human hepatoma cell line J Hepatol (submitted)

  19. Bartolome J, Madejon A, Carreno V . Ribozymes: structure, characteristics and use as potential antiviral agents J Hepatol 1995 22: 57–64

    Article  CAS  Google Scholar 

  20. Offensperger WB, Blum HE, Gerok W . Molecular therapeutic strategies in hepatitis B virus infection Clin Invest 1994 72: 737–741

    Article  CAS  Google Scholar 

  21. Sczakiel G, Nedbal W . The potential of ribozymes as antiviral agents Trends Microbiol 1995 3: 213–217

    Article  CAS  Google Scholar 

  22. Shillitoe EJ, Kamath P, Chen Z . Papillomaviruses as targets for cancer gene therapy Cancer Gene Ther 1994 1: 193–204

    CAS  PubMed  Google Scholar 

  23. Larsson S et al. Reduced beta 2-macroglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme Nucleic Acids Res 1994 22: 2242–2248

    Article  CAS  Google Scholar 

  24. Lieber A, Kay MA . Adenovirus-mediated expression of ribozymes in mice J Virol 1996 70: 3153–3158

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Thompson JD et al. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter Nucleic Acids Res 1995 23: 2259–2268

    Article  CAS  Google Scholar 

  26. Sullinger BA et al. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Mol Cell Biol 1990 10: 6512–6523

    Article  Google Scholar 

  27. Kirschmeier PT et al. Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences DNA 1988 7: 219–225

    Article  CAS  Google Scholar 

  28. Wilkinson DA et al. Autonomous expression of RTUL-H endogenous retrovirus-like elements in human cells J Virol 1990 64: 2157–2167

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Ozaki I et al. Application of ribozymes for gene therapy of liver disease in α1-antitrypsin deficiency In: Molecular Diagnosis and Gene Therapy Kluwer Academic: Dordrecht 1996 pp 106–115

    Google Scholar 

  30. Scharfmann R, Axelrod JH, Verma IM . Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblasts implants Proc Natl Acad Sci USA 1991 88: 4626–4630

    Article  CAS  Google Scholar 

  31. Strayer DS et al. Titering replication-defective virus for use in gene transfer Biotechniques 1997 22: 447–449

    Article  CAS  Google Scholar 

  32. Rosenberg BH, Deutsch JF, Ungers GE . Growth and purification of SV40 virus for biochemical studies J Virol Meth 1981 3: 167–176

    Article  CAS  Google Scholar 

  33. Chomczynski P, Sacchi N . Single-step method of RNA extraction by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 1987 162: 156–159

    Article  CAS  Google Scholar 

  34. Frizell E et al. Expression of SPARC in normal and fibrotic livers Hepatology 1995 21: 847–854

    CAS  PubMed  Google Scholar 

  35. Yun-Tso J et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene Nucleic Acids Res 1985 13: 2485–2502

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zern, M., Ozaki, I., Duan, L. et al. A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Ther 6, 114–120 (1999). https://doi.org/10.1038/sj.gt.3300793

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300793

Keywords

This article is cited by

Search

Quick links